Skip to main content

Advertisement

SpringerLink
Log in

Previous antiplatelet therapy is an independent predictor of 30–day mortality after spontaneous supratentorial intracerebral hemorrhage

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background

Intracerebral hemorrhage (ICH) constitutes 10% to 15% of all strokes. Despite several existing outcome prediction models for ICH, there are some factors with equivocal value as well as others that still have not been evaluated.

Patients and methods

All patients with first ever supratentorial ICH presenting to our institution between December 1995 and December 2002 were prospectively enrolled into the study. Patients with historic modified Rankin Scale > 2 and those under anticoagulant treatment or with multiple ICH were excluded. The following parameters were analyzed in 194 consecutive patients: age, gender, past history of hypertension, diabetes mellitus, hypercholesterolemia, past history of ischemic stroke, presence of ischemic heart disease or cardioembolic disease, current antiplatelet treatment, current alcohol overuse, smoking, Glasgow Coma Scale score (GSS) at admission, volume and location (deep or lobar) of ICH, ventricular extension, glycemia and temperature at admission, and leukoaraiosis. We correlated these data with the 30–day mortality identifying the independent predictors by logistic regression analysis.

Results

Factors independently associated with 30–day mortality were: age, Glasgow Coma Scale score at admission, ICH volume, ventricular extension, glucose level at admission, and previous antiplatelet use.

Conclusions

Apart from the classical outcome predictors, the previous use of antiplatelet agents and the glucose value at admission are independent predictors of 30–day mortality in patients suffering a supratentorial ICH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arboix A, Massons J, Garcia-Eroles L, Oliveres M, Targa C (2000) Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care 23:1527–1532

    Google Scholar 

  2. Baptista MV, van Melle G, Bogousslavsky J (1999) Prediction of in-hospital mortality after first-ever stroke: the Lausanne Stroke Registry. J Neurol Sci 166:107–114

    Google Scholar 

  3. Berwaerts J, Dijkhuizen RS, Robb OJ, Webster J (2000) Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage. Stroke 31:2558–2562

    Google Scholar 

  4. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G (1993) Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24:987–993

    Google Scholar 

  5. Cheung RT, Zou LY (2003) Use of the Original,Modified, or New Intracerebral Hemorrhage Score to Predict Mortality and Morbidity After Intracerebral Hemorrhage. Stroke 34:1717–1722

    Google Scholar 

  6. Daverat P, Castel JP, Dartigues JF, Orgogozo JM (1991) Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 22:1–6

    Google Scholar 

  7. el Chami B, Milan C, Giroud M, Sautreaux JL, Faivre J (2000) Intracerebral hemorrhage survival: French register data. Neurol Res 22:791–796

    Google Scholar 

  8. Fieschi C, Carolei A, Fiorelli M, Argentino C, Bozzao L, Fazio C, Salvetti M, Bastianello S (1988) Changing prognosis of primary intracerebral hemorrhage: results of a clinical and computed tomographic follow-up study of 104 patients. Stroke 19:192–195

    Google Scholar 

  9. Fogelholm R, Avikainen S, Murros K (1997) Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 28:1396–1400

    Google Scholar 

  10. Franke CL, van Swieten JC, Algra A, van Gijn J (1992) Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry 55:653–657

    Google Scholar 

  11. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R (1998) Multivariate Analysis of Predictors of Hematoma Enlargement in Spontaneous Intracerebral Hemorrhage. Stroke 29:1160–1166

    Google Scholar 

  12. Hallevy C, Ifergane G, Kordysh E, Herishanu Y (2002) Spontaneous supratentorial intracerebral hemorrhage. Criteria for short-term functional outcome prediction. J Neurol 249:1704–1709

    Google Scholar 

  13. Hardemark HG, Wesslen N, Persson L (1999) Influence of clinical factors, CT findings and early management on outcome in supratentorial intracerebral hemorrhage. Cerebrovasc Dis 9:10–21

    Google Scholar 

  14. He J, Whelton PK, Vu B, Klag MJ (1998) Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 280:1930–1935

    Google Scholar 

  15. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC (2001) The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32:891–897

    Google Scholar 

  16. Johnsen SP, Pedersen L, Friis S, Blot WJ, McLaughlin JK, Olsen JH, Sorensen HT (2003) Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based casecontrol study. Stroke 34:387–391

    Google Scholar 

  17. Juvela S (1995) Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol 52:1193–1200

    Google Scholar 

  18. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304–1305

    Google Scholar 

  19. Kronmal RA, Hart RG, Manolio TA, Talbert RL, Beauchamp NJ, Newman A (1998) Aspirin use and incident stroke in the cardiovascular health study. CHS Collaborative Research Group. Stroke 29:887

    Google Scholar 

  20. Kurth T, Kase CS, Berger K, Schaeffner ES, Buring JE, Gaziano JM (2003) Smoking and the risk of hemorrhagic stroke in men. Stroke 34:1151–1155

    Google Scholar 

  21. Lampl Y, Gilad R, Eshel Y, Sarova-Pinhas I (1995) Neurological and functional outcome in patients with supratentorial hemorrhages. A prospective study. Stroke 26:2249–2253

    Google Scholar 

  22. Larrue V, von Kummer RR, Muller A, Bluhmki E (2001) Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European- Australasian Acute Stroke Study (ECASS II). Stroke 32:438–441

    Google Scholar 

  23. Matias-Guiu J, Ferro JM, Alvarez-Sabin J, Torres F, Jimenez MD, Lago A, Melo T; TACIP Investigators (2003) Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind,multicenter trial. Stroke 34:840–848

    Google Scholar 

  24. Neau JP, Couderq C, Ingrand P, Blanchon P, Gil R; VGP Study Group (2001) Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc Dis 11:195–200

    Google Scholar 

  25. Nilsson OG, Lindgren A, Brandt L, Saveland H (2002) Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg 97:531–536

    Google Scholar 

  26. Qureshi AI, Safdar K, Weil J, Barch C, Bliwise DL, Colohan AR, Mackay B, Frankel MR (1995) Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 26:1764–1767

    Google Scholar 

  27. Radberg JA, Olsson JE, Radberg CT (1991) Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 22:571–576

    Google Scholar 

  28. Rosand J, Hylek EM, O’Donnell HC, Greenberg SM (2000) Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55:947–951

    Google Scholar 

  29. Rosenow F, Hojer C, Meyer-Lohmann C, Hilgers RD, Muhlhofer H, Kleindienst A, Owega A, Koning W, Heiss WD (1997) Spontaneous intracerebral hemorrhage. Prognostic factors in 896 cases. Acta Neurol Scand 96:174–182

    Google Scholar 

  30. Saloheimo P, Juvela S, Hillbom M (2001) Use of aspirin, epistaxis, and untreated hypertension as risk factors for primary intracerebral hemorrhage in middle-aged and elderly people. Stroke 32:399–404

    Google Scholar 

  31. Tatu L, Moulin T, El Mohamad R, Vuillier F, Rumbach L, Czorny A (2000) Primary intracerebral hemorrhages in the Besançon stroke registry. Initial clinical and CT findings, early course and 30-day outcome in 350 patients. Eur Neurol 43:209–214

    Google Scholar 

  32. Terayama Y, Tanahashi N, Fukuuchi Y, Gotoh F (1997) Prognostic value of admission blood pressure in patients with intracerebral hemorrhage. Keio Cooperative Stroke Study. Stroke 28:1185–1188

    Google Scholar 

  33. Tuhrim S, Horowitz DR, Sacher M, Godbold JH (1999) Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 27:617–621

    Google Scholar 

  34. Wong KS, Mok V, Lam WWM, Kay R, Tang A, Chan YL, Woo J (2000) Aspirin- associated intracerebral hemorrhage. Clinical and radiologic features. Neurology 54:2298–2301

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unitat d’Ictus, Servei de Neurología, Hospital del Mar, Passeig Marítim 25–29, 08003, Barcelona, Spain

    Jaume Roquer MD, PhD, Ana Rodríguez Campello MD, Meritxell Gomis MD, Angel Ois MD, Victor Puente MD & Elvira Munteis MD

Authors
  1. Jaume Roquer MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Rodríguez Campello MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Meritxell Gomis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angel Ois MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Victor Puente MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elvira Munteis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaume Roquer MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roquer, J., Rodríguez Campello, A., Gomis, M. et al. Previous antiplatelet therapy is an independent predictor of 30–day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol 252, 412–416 (2005). https://doi.org/10.1007/s00415-005-0659-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0659-5

Key words

Search

Navigation